Page last updated: 2024-08-18

xanthenes and ER-Negative PR-Negative HER2-Negative Breast Cancer

xanthenes has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bai, Y; Chen, S; Dou, D; Gao, W; Liu, H; Liu, Y; Meng, J; Sun, T; Tang, Y; Yang, C; Yang, L; Yang, W; Zhang, H; Zhang, X; Zhong, W	1
Bialecki, E; Biernat, W; Brastianos, PK; Difilippantonio, S; Dolan, EL; Duchnowska, R; Figg, WD; Gril, B; Hall, OM; Hanson, J; Hua, E; Izycka-Swieszewska, E; Jassem, J; Kloc, W; Metellus, P; Nayyar, N; Paranjape, AN; Pauly, GT; Peer, CJ; Pęksa, R; Robinson, C; Schneider, JP; Steeg, PS; Woditschka, S; Wu, X	1

Other Studies

2 other study(ies) available for xanthenes and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells. Journal for immunotherapy of cancer, 2019, 08-28, Volume: 7, Issue:1 Topics: Animals; Antibodies, Monoclonal; Apoptosis; Cell Proliferation; Drug Synergism; Female; Immunotherapy; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Monosaccharides; Myeloid-Derived Suppressor Cells; Programmed Cell Death 1 Receptor; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Tumor Microenvironment; Xanthenes	2019
Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases. Nature communications, 2018, 07-13, Volume: 9, Issue:1 Topics: Animals; Antibiotics, Antineoplastic; Astrocytes; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Chemokine CCL2; Doxorubicin; Female; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Humans; Injections, Intramuscular; Interleukin-6; Mice, Nude; Myocardium; Permeability; Receptors, Lysosphingolipid; Signal Transduction; Triple Negative Breast Neoplasms; Xanthenes	2018

Article

Year

Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells.

Journal for immunotherapy of cancer, 2019, 08-28, Volume: 7, Issue:1

Topics: Animals; Antibodies, Monoclonal; Apoptosis; Cell Proliferation; Drug Synergism; Female; Immunotherapy; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Monosaccharides; Myeloid-Derived Suppressor Cells; Programmed Cell Death 1 Receptor; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Tumor Microenvironment; Xanthenes

2019

Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases.

Nature communications, 2018, 07-13, Volume: 9, Issue:1

Topics: Animals; Antibiotics, Antineoplastic; Astrocytes; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Chemokine CCL2; Doxorubicin; Female; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Humans; Injections, Intramuscular; Interleukin-6; Mice, Nude; Myocardium; Permeability; Receptors, Lysosphingolipid; Signal Transduction; Triple Negative Breast Neoplasms; Xanthenes

2018